CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Q-Line Biotech Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Q-Line Biotech Ltd
298-281, Transport Nagar
Phone: +91 5222433023p:+91 5222433023 LUCKNOW, 226023  India Ticker: QLINEQLINE
Business Summary
Q-Line Biotech Ltd is engaged in the business of developing, manufacturing and marketing a diverse range of reagents (including kits and POC devices) and consumables and manufacturing, importing, distribution/supply of diagnostic equipment for different diagnostic healthcare needs. The Company supplies diagnostic equipment and IVD products for different diagnostic healthcare needs directly or through its distributors, who in turn sell its products to hospitals/diagnostic centers or directly to diagnostic service providers and hospitals. It has developed a diversified product portfolio in the IVD industry which includes reagents, point of care devices and kits used in clinical chemistry, coagulation, hematology, HPLC, rapid/ELISA, molecular, diagnostic instruments, equipment, consumables and services. It markets these products in around 26 states and the Union Territory with specific focus on Utter Pradesh, Rajasthan, Madhya Pradesh, Kerala and Odisha.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/20253/31/2025-----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3826 Laboratory analytical instruments
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Financial Officer MeenakshiDass 60 7/25/2025 7/25/2025
Whole-Time Director KuldeepChowdhry 52 8/1/2025 9/28/2015
Whole-Time Director Ajay K.Mahanty 46 8/1/2025 9/28/2015
7 additional Officers and Directors records available in full report.

General Information
Outstanding Shares: 23,328,199 (As of 12/31/2025)
Stock Exchange: NSE


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, June 1, 2026